Gilead Sciences Aktie
81,88
EUR
-2,25
EUR
-2,67
%
88,04
USD
-0,42
USD
-0,47
%
Gilead Sciences Aktie Analyse
| 15.06.20 | Gilead Sciences kaufen | DZ BANK | |
| 15.03.19 | Gilead Sciences Outperform | BMO Capital Markets | |
| 03.01.19 | Gilead Sciences Outperform | Oppenheimer & Co. Inc. | |
| 26.10.18 | Gilead Sciences overweight | Barclays Capital | |
| 01.10.18 | Gilead Sciences Overweight | Cantor Fitzgerald | |
| 02.05.18 | Gilead Sciences Buy | Maxim Group | |
| 06.03.18 | Gilead Sciences overweight | Barclays Capital | |
| 12.02.18 | Gilead Sciences Buy | Mizuho | |
|
Werbung
|
|||
| 30.11.17 | Gilead Sciences Buy | Maxim Group | |
| 08.11.17 | Gilead Sciences Buy | Mizuho | |
| 11.10.17 | Gilead Sciences overweight | Barclays Capital | |
| 15.09.17 | Gilead Sciences Outperform | RBC Capital Markets | |
| 23.06.17 | Gilead Sciences Buy | Deutsche Bank AG | |
| 14.11.16 | Gilead Sciences Buy | Stifel, Nicolaus & Co., Inc. | |
| 08.11.16 | Gilead Sciences Buy | Mizuho | |
| 02.11.16 | Gilead Sciences Outperform | RBC Capital Markets | |
| 03.10.16 | Gilead Sciences Outperform | RBC Capital Markets | |
| 01.06.16 | Gilead Sciences Buy | Gabelli & Co | |
| 29.04.16 | Gilead Sciences Buy | UBS AG | |
| 08.04.16 | Gilead Sciences Market Perform | BMO Capital Markets | |
| 28.10.15 | Gilead Sciences Buy | Maxim Group | |
| 20.10.15 | Gilead Sciences Outperform | Oppenheimer & Co. Inc. | |
| 29.07.15 | Gilead Sciences overweight | Barclays Capital | |
| 29.07.15 | Gilead Sciences Buy | Deutsche Bank AG | |
| 29.07.15 | Gilead Sciences Outperform | Oppenheimer & Co. Inc. | |
| 29.07.15 | Gilead Sciences Buy | Needham & Company, LLC | |
| 29.07.15 | Gilead Sciences Buy | Maxim Group | |
| 29.07.15 | Gilead Sciences Outperform | RBC Capital Markets | |
| 23.06.15 | Gilead Sciences Buy | Argus Research Company | |
| 01.05.15 | Gilead Sciences Outperform | RBC Capital Markets | |
| 04.02.15 | Gilead Sciences Outperform | RBC Capital Markets | |
| 23.12.14 | Gilead Sciences Buy | Deutsche Bank AG | |
| 09.12.14 | Gilead Sciences Buy | Argus Research Company | |
| 29.10.14 | Gilead Sciences Outperform | RBC Capital Markets | |
| 13.10.14 | Gilead Sciences Outperform | FBR Capital | |
| 25.09.14 | Gilead Sciences Buy | Needham & Company, LLC | |
| 11.01.13 | Gilead Sciences kaufen | boerse.de-Aktienbrief | |
| 10.01.13 | Gilead Sciences kaufen | Aktienservice Research | |
| 18.12.12 | Gilead Sciences buy | UBS AG | |
| 03.12.12 | Gilead Sciences overweight | Piper Jaffray & Co. | |
| 15.11.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 14.11.12 | Gilead Sciences buy | Deutsche Bank Securities | |
| 13.11.12 | Gilead Sciences buy | Stifel, Nicolaus & Co., Inc. | |
| 12.11.12 | Gilead Sciences buy | UBS AG | |
| 07.11.12 | Gilead Sciences outperform | Sanford C. Bernstein and Co., Inc. | |
| 25.10.12 | Gilead Sciences buy | Needham & Company, LLC | |
| 15.10.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 03.10.12 | Gilead Sciences buy | UBS AG | |
| 02.10.12 | Gilead Sciences outperform | Sanford C. Bernstein and Co., Inc. | |
| 27.09.12 | Gilead Sciences outperform | RBC Capital Markets | |